Press Releases

Kerecis Establishes Scientific Advisory Board of Leading Experts in Wound Care and Surgical Implants

• August 8th, 2013

New Board Members Join Kerecis

• June 17th, 2013

Kerecis Completes Successful Immunology Study

• May 3rd, 2013

Kerecis Completes US$ 1 Million Series A2 Funding

• April 26th, 2013

Kerecis Announces a Distribution Agreement with Medline Industries for the MariGen Omega3 Tissue-regeneration Technology

• January 31st, 2013

Follow-Up Study Demonstrates Safety and Efficacy of Omega3 Wound-Healing Treatment

• May 18th, 2012

Clinical Trial Demonstrates Safety and Efficacy of Wound-Healing Treatment

• October 6th, 2011

Minister of Industry Inaugurates Fish Skin Medical Device Facility

• September 26th, 2011

Kerecis to Present at IN3 East Investor Conference in Boston, June 21 – 23, 2011

• June 20th, 2011

Kerecis Completes Interim Financing

• May 24th, 2011

Kerecis Limited Receives ISO 13485:2003 Quality Management System Certification

• March 24th, 2011

Kerecis to Present at Investment Forums in London and New York

• November 3rd, 2010

Kerecis Announces New Directors Eythor Bender and Egill Masson

• October 8th, 2010

Research Collaboration Between Kerecis and ValaMed

• July 14th, 2010

Kerecis to Present at IN3 East Investor Conference in Boston, June 10 – 11, 2010

• June 9th, 2010

Kerecis Announces New VP of Science and Technology

• May 3rd, 2010

Kerecis Closes Start-Up Financing Round with the New Business Venture Fund

• January 1st, 2010

Kerecis to Present at the 10th Seed Forum Iceland Conference

• September 30th, 2009